L carnitine in hemodialysis patients

被引:25
|
作者
Calo, Lorenzo A. [1 ]
Vertolli, Ugo [2 ]
Davis, Paul A. [3 ]
Savica, Vincenzo [4 ]
机构
[1] Univ Padua, Dept Med, I-35128 Padua, Italy
[2] Univ Padua, Azienda Osped Padova, Div Nephrol, I-35128 Padua, Italy
[3] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[4] Univ Messina, Div Nephrol, Messina, Italy
关键词
Carnitine; chronic renal failure; dialysis; anemia; insulin resistance; STAGE RENAL-DISEASE; LEFT-VENTRICULAR FUNCTION; FATTY-ACID-METABOLISM; HEME OXYGENASE-1; SKELETAL-MUSCLE; ENDOGENOUS PLASMA; SUPPLEMENTATION; ERYTHROPOIETIN; DIALYSIS; ANTIOXIDANT;
D O I
10.1111/j.1542-4758.2012.00679.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Carnitine, 3-hydroxy-4-trimethylaminobutyrate, a small, water soluble molecule that is essential for mitochondrial fatty acid oxidation, is significantly reduced in hemodialysis patients. Uremia-induced carnitine deficiency, which is magnified by dialysis, is associated with symptoms or clinical problems such as anemia hyporesponsive to erythropoietin, cardiovascular diseases, and muscle weakness. This review examines studies dealing with the different clinical aspects of chronic renal failure patients in which carnitine deficiency may play a role and has also examined the studies, which have evaluated the effect of carnitine deficiency treatment. The reports reviewed in this study, including those more recent from our laboratory, have provided data suggesting that chronic renal failure and particularly hemodialysis patients can benefit from carnitine treatment in particular for renal anemia, insulin sensitivity, and protein catabolism. On the other hand, the heterogeneous clinical response to carnitine therapy in dialysis patients, reported by other studies, and the lack of large-scale randomized trials are the rationale for the reluctance regarding a widespread use of carnitine supplements in dialysis patients. Well-designed randomized clinical trials are therefore required to fully address the potentially important carnitine treatment in dialysis patients.
引用
收藏
页码:428 / 434
页数:7
相关论文
共 50 条
  • [41] Effect of L-carnitine on the calcium content of erythrocytes of uremic patients on hemodialysis
    Agroyannis, B
    Paraskevopoulos, A
    Fourtounas, C
    Tzanatos, H
    Tsomi, A
    Vlahakos, D
    Dalamangas, A
    DIALYSIS & TRANSPLANTATION, 2002, 31 (02) : 106 - +
  • [42] Adult hemodialysis patients: A prospective study on the use of intravenous L-carnitine
    Yazar, H.
    Kayhan, B. C.
    Basarali, K. M.
    Balci, M.
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (11): : 1349 - 1352
  • [43] Influence of supplementation with L-carnitine on parathyroid function in hemodialysis (HD) patients
    Racek, J
    Vesela, E
    Cibulka, R
    Trefil, L
    Malanova, L
    CLINICAL CHEMISTRY, 2004, 50 (06) : A101 - A101
  • [44] Effects of L-carnitine supplementation in maintenance Hemodialysis patients: A systematic review
    Hurot, JM
    Cucherat, M
    Haugh, M
    Fouque, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (03):
  • [45] Neuroprotective Effects of L-Carnitine on Vascular Dementia in Hemodialysis Patients.
    Ueno, Yuji
    Urabe, Takao
    Hattori, Nobutaka
    STROKE, 2021, 52
  • [46] CARNITINE AND WEAKNESS IN HEMODIALYSIS-PATIENTS
    ROGERSON, ME
    RYLANCE, PB
    WILSON, R
    DESOUSA, C
    LANIGAN, C
    ROSE, PE
    HOWARD, J
    PARSONS, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (05) : 366 - 371
  • [47] Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Hemodialysis
    Hatanaka, Yoshinari
    Higuchi, Terumi
    Akiya, Yurie
    Horikami, Tomomi
    Tei, Ritsukou
    Furukawa, Tetsuya
    Takashima, Hiroyuki
    Tomita, Hyoe
    Abe, Masanori
    BLOOD PURIFICATION, 2019, 47 : 38 - 44
  • [48] MULTICENTER TRIAL OF L-CARNITINE IN MAINTENANCE HEMODIALYSIS-PATIENTS .1. CARNITINE CONCENTRATIONS AND LIPID EFFECTS
    GOLPER, TA
    WOLFSON, M
    AHMAD, S
    HIRSCHBERG, R
    KURTIN, P
    KATZ, LA
    NICORA, R
    ASHBROOK, D
    KOPPLE, JD
    KIDNEY INTERNATIONAL, 1990, 38 (05) : 904 - 911
  • [49] Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients
    Brass, EP
    Adler, S
    Sietsema, KE
    Hiatt, WR
    Orlando, AM
    Amato, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (05) : 1018 - 1028
  • [50] Associations of oral L-carnitine with hemoglobin, lipid profile, and albumin in hemodialysis patients
    Mortazavi, Mojgan
    Seirafian, Shiva
    Eshaghian, Afrooz
    Ghassami, Maryam
    Taheri, Shahram
    Atapour, Abdolamir
    Hassanzadeh, Akbar
    Bayat, Ahmad
    Moinzadeh, Firoozeh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 : S33 - S37